486 related articles for article (PubMed ID: 29945766)
21. Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population.
Yi X; Lin J; Zhou Q; Wu L; Cheng W; Wang C
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1222-1228. PubMed ID: 26935114
[TBL] [Abstract][Full Text] [Related]
22. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
23. Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study.
Rosafio F; Lelli N; Mimmi S; Vandelli L; Bigliardi G; Dell'Acqua ML; Picchetto L; Pentore R; Ferraro D; Trenti T; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1864-1873. PubMed ID: 28576652
[TBL] [Abstract][Full Text] [Related]
24. High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents.
Lv H; Yang Z; Wu H; Liu M; Mao X; Liu X; Ding H; Shi Z; Zhou Y; Liu Q; Zhang Y; Zhou Y; Chen K; Li Z; Dong Q; Ma J; Han Y
Transl Stroke Res; 2022 Jun; 13(3):391-398. PubMed ID: 34596891
[TBL] [Abstract][Full Text] [Related]
25. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
26. High on-treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta-analysis.
Zhou K; Yu S; Li J; Tan Y; Xing S; Chen Y; Ouyang F; Zeng J; Zhang J
Acta Neurol Scand; 2022 Sep; 146(3):205-224. PubMed ID: 35652290
[TBL] [Abstract][Full Text] [Related]
27. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF
CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117
[TBL] [Abstract][Full Text] [Related]
28. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
[TBL] [Abstract][Full Text] [Related]
29. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
Yang C; Qian J; Tang X; Gao P; Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
[TBL] [Abstract][Full Text] [Related]
30. Platelet reactivity in MitraClip patients.
Polzin A; Afzal S; Balzer J; Rassaf T; Kelm M; Zeus T
Vascul Pharmacol; 2016 Feb; 77():54-9. PubMed ID: 26239882
[TBL] [Abstract][Full Text] [Related]
31. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
32. Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.
Lu M
Pak J Pharm Sci; 2017 Jan; 30(1):217-221. PubMed ID: 28603135
[TBL] [Abstract][Full Text] [Related]
33. Impact of CYP2C19 Polymorphisms on Clinical Outcomes and Antiplatelet Potency of Clopidogrel in Caucasian Poststroke Survivors.
Tomek A; Matʼoška V; Frýdmanová A; Magerová H; Šrámek M; Paulasova-Schwabová J; Růžičková T; Janský P; Šarbochová I; Hadačová I; Kaplan V; Lacinová Z; Táborský L; Serebruany V
Am J Ther; 2018; 25(2):e202-e212. PubMed ID: 29509167
[TBL] [Abstract][Full Text] [Related]
34. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
[TBL] [Abstract][Full Text] [Related]
35. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
[TBL] [Abstract][Full Text] [Related]
36. Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.
Rath CL; Jørgensen NR; Wienecke T
PLoS One; 2020; 15(12):e0236260. PubMed ID: 33370281
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up.
Xu H; Ping Y; Lin H; He P; Li W; Dai H
Transl Stroke Res; 2017 Jun; 8(3):228-233. PubMed ID: 28039577
[TBL] [Abstract][Full Text] [Related]
38. [Clopidogrel resistance in cerebrovascular disease -- results of one-year follow-up].
Szapáry L; Koltai K; Tibold A; Fehér A; Harang G; Pusch G; Fehér G
Orv Hetil; 2015 Jan; 156(2):53-9. PubMed ID: 25563682
[TBL] [Abstract][Full Text] [Related]
39. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.
Weimar C; Cotton D; Sha N; Sacco RL; Bath PM; Weber R; Diener HC
Cerebrovasc Dis; 2013; 35(6):538-43. PubMed ID: 23816610
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
